| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_RP11-370K11.1_0000700 | Intron-Intron | chr1:243893222-243893508 | chr1:243729920-243730206 | 287 nt | 0.4843 |
| hsa_RP11-370K11.1_0000800 | Intron-Intron | chr1:243895261-243895583 | chr1:243731959-243732281 | 323 nt | 0.4087 |
| hsa_RP11-370K11.1_0000900 | Intron-Exon | chr1:243903911-243904087 | chr1:243740609-243740785 | 177 nt | 0.4068 |
| hsa_SDCCAG8_0019500 | Exon-Intergenic | chr1:243663102-243664228 | chr1:243499800-243500926 | 1127 nt | 0.3931 |
A study in mice demonstrated that the circAKT3 is highly expressed in brain tissue and plays a crucial role in brain development and neurological disorders [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in human traumatic brain injury (TBI) brain tissues identified the circAKT3 as a top down-regulated circular RNA, with a fold change of 0.44, and its decreased expression was validated by qRT-PCR [Li et al. DOI:10.3389/fneur.2022.1086553].